Contralateral Prophylactic Mastectomy and Implications for Breast Reconstruction

Overview

Journal Gland Surg

Publisher AME Publishing Company

Specialty Endocrinology

Date 2021 Feb 26

PMID 33634008

Citations 7

Authors

Katherine B Santosa

Jeremie D Oliver

Adeyiza O Momoh

Affiliations

Soon will be listed here.

Abstract

Contralateral prophylactic mastectomy (CPM) rates have continued to rise in the United States, impacting all stakeholders including plastic and reconstructive surgeons. Multiple factors may be influencing this trend, including patient decision-making characteristics, knowledge about breast cancer disease and prognosis, advances in genetic testing and enhanced imaging capabilities, sociodemographic factors, and access to specialty surgical services such as breast reconstruction. In this review, the authors shed light on the current state of CPM and summarize the literature analyzing its increasing prevalence in the United States, as well as outline future directions for study and dissemination of knowledge from providers to patients surrounding this important and complex treatment decision.

Citing Articles

Efficacy and Safety of Barbed Sutures for Capsulorrhaphy in Implant-Based Breast Reconstruction.

Tyle M, Nester M, McLaughlin M, Olafson A, Le N, Whalen K Eplasty. 2024; 24:e50.

PMID: 39474008 PMC: 11520367.

Are There Disparities in Breast Reconstruction After Contralateral Prophylactic Mastectomy?.

Lattimore C, Meneveau M, Desai R, Camacho T, Squeo G, Showalter S J Surg Res. 2024; 298:277-290.

PMID: 38636184 PMC: 11144118. DOI: 10.1016/j.jss.2024.03.010.

Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction.

Diao K, Lei X, He W, Jagsi R, Giordano S, Smith G Ann Surg. 2023; 278(5):e1096-e1102.

PMID: 37232937 PMC: 10592600. DOI: 10.1097/SLA.0000000000005920.

EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.

Schmidt M, Kelly J, Bredart A, Cameron D, de Boniface J, Easton D Eur J Cancer. 2023; 181:79-91.

PMID: 36641897 PMC: 10326619. DOI: 10.1016/j.ejca.2022.11.036.

Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations.

Thompson J, Sinco B, McCaffrey R, Chang A, Sabel M, Dossett L J Surg Oncol. 2022; 127(1):18-27.

PMID: 36069388 PMC: 10087968. DOI: 10.1002/jso.27088.

References

Buchanan P, Abdulghani M, Waljee J, Kozlow J, Sabel M, Newman L . An Analysis of the Decisions Made for Contralateral Prophylactic Mastectomy and Breast Reconstruction. Plast Reconstr Surg. 2016; 138(1):29-40. DOI: 10.1097/PRS.0000000000002263. View

Bedrosian I, Hu C, Chang G . Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010; 102(6):401-9. PMC: 4415082. DOI: 10.1093/jnci/djq018. View

Bennett K, Qi J, Kim H, Hamill J, Pusic A, Wilkins E . Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg. 2018; 153(10):901-908. PMC: 6233788. DOI: 10.1001/jamasurg.2018.1687. View

Covelli A, Baxter N, Fitch M, Wright F . Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: a comparative analysis between Canada and the United States. Ann Surg Oncol. 2014; 21(10):3173-84. DOI: 10.1245/s10434-014-3955-4. View

Sando I, Billig J, Ambani S, Kraft C, Kidwell K, Zhong L . An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort. Ann Plast Surg. 2017; 80(4):333-338. DOI: 10.1097/SAP.0000000000001258. View

Blair I, Steiner J, Fairclough D, Hanratty R, Price D, Hirsh H . Clinicians' implicit ethnic/racial bias and perceptions of care among Black and Latino patients. Ann Fam Med. 2013; 11(1):43-52. PMC: 3596038. DOI: 10.1370/afm.1442. View

Momoh A, Griffith K, Hawley S, Morrow M, Ward K, Hamilton A . Patterns and Correlates of Knowledge, Communication, and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer. Plast Reconstr Surg. 2019; 144(2):303-313. PMC: 6662624. DOI: 10.1097/PRS.0000000000005803. View

Boughey J, Hoskin T, Degnim A, Sellers T, Johnson J, Kasner M . Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol. 2010; 17(10):2702-9. PMC: 3964596. DOI: 10.1245/s10434-010-1136-7. View

Deshmukh A, Cantor S, Crosby M, Dong W, Shen Y, Bedrosian I . Cost of contralateral prophylactic mastectomy. Ann Surg Oncol. 2014; 21(9):2823-30. PMC: 4125517. DOI: 10.1245/s10434-014-3759-6. View

10.

Hwang E, Locklear T, Rushing C, Samsa G, Abernethy A, Hyslop T . Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy. J Clin Oncol. 2016; 34(13):1518-27. DOI: 10.1200/JCO.2015.61.5427. View

11.

Politi M, Lee C, Philpott-Streiff S, Foraker R, Olsen M, Merrill C . A Randomized Controlled Trial Evaluating the BREASTChoice Tool for Personalized Decision Support About Breast Reconstruction After Mastectomy. Ann Surg. 2019; 271(2):230-237. DOI: 10.1097/SLA.0000000000003444. View

12.

Yi M, Hunt K, Arun B, Bedrosian I, Gutierrez Barrera A, Do K . Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010; 3(8):1026-34. PMC: 4340054. DOI: 10.1158/1940-6207.CAPR-09-0130. View

13.

Lehman C, Gatsonis C, Kuhl C, Hendrick R, Pisano E, Hanna L . MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356(13):1295-303. DOI: 10.1056/NEJMoa065447. View

14.

Craft R, Colakoglu S, Curtis M, Yueh J, Lee B, Tobias A . Patient satisfaction in unilateral and bilateral breast reconstruction [outcomes article]. Plast Reconstr Surg. 2011; 127(4):1417-1424. DOI: 10.1097/PRS.0b013e318208d12a. View

15.

Rebbeck T, Friebel T, Lynch H, Neuhausen S, van t Veer L, Garber J . Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004; 22(6):1055-62. DOI: 10.1200/JCO.2004.04.188. View

16.

Panchal H, Pilewskie M, Sheckter C, Albornoz C, Razdan S, Disa J . National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer. J Surg Oncol. 2018; 119(1):79-87. PMC: 6327316. DOI: 10.1002/jso.25315. View

17.

Bevers T, Armstrong D, Arun B, Carlson R, Cowan K, Daly M . Breast cancer risk reduction. J Natl Compr Canc Netw. 2010; 8(10):1112-46. DOI: 10.6004/jnccn.2010.0083. View

18.

Silva A, Lapin B, Yao K, Song D, Sisco M . The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. Ann Surg Oncol. 2015; 22(11):3474-80. DOI: 10.1245/s10434-015-4628-7. View

19.

Murthy V, Chamberlain R . Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?. Clin Breast Cancer. 2013; 13(3):180-7. DOI: 10.1016/j.clbc.2012.12.001. View

20.

Alba B, Schultz B, Cohen D, Qin A, Chan W, Tanna N . Risk-to-Benefit Relationship of Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies with Immediate Reconstruction. Plast Reconstr Surg. 2019; 144(1):1-9. DOI: 10.1097/PRS.0000000000005690. View